Changes in Circulating Biomarkers in Patients With Ischemic Heart Failure After Treatment With Autologous Mesenchymal Stromal Cells and c-Kit-Positive Cardiac Cells, Alone or in Combination: Results From the Cardiovascular Cell Therapy Research Network CONCERT-HF Clinical Trial.

J Am Heart Assoc · 2026 · PMC13279071 · PMID 42003602

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although more patients were classified as having New York Heart Association class III heart failure in the MSCs cohort (n=6, 30%) than in the MSCs+CPCs (n=4, 22.2%), the CPCs (n=2, 9.5%), and the placebo (n=3, 8.1%) cohorts, these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.